3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Age‐related cognitive decline in myotonic dystrophy type 1: An 11‐year longitudinal follow‐up study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Myotonic dystrophy type 1 ( DM1) is an inherited multi‐systemic disease involving the central nervous system ( CNS) and is consequently characterized by a range of cognitive impairments. However, whether this cognitive profile progresses over time is still a matter of debate. The aim of this study was to longitudinally assess a DM1 sample, in order to compare, for the first time, this progression with that of a control group. Clinical and socio‐demographic predictive factors potentially implicated in this possible decline are analysed.

          Method

          Seventy‐five DM1 patients with childhood, juvenile, adult, and late‐onset, and 54 control participants were re‐assessed in an 11‐year follow‐up with a comprehensive neuropsychological battery. The analyses employed were mixed ANOVA for repeated measures to test intergroup comparisons over time and multiple linear regression for predictive variable analysis.

          Results

          Myotonic dystrophy type 1 patients significantly worsened in visuospatial/visuoconstructive abilities and visual memory compared with controls. Multiple linear regression revealed that progression of cognitive impairment measured by copy of the Rey–Osterrieth complex figure was predicted by muscular impairment, whilst on the block design test age predicted the change with a cut‐off at 31 years of age.

          Discussion

          A domain‐specific progressive cognitive decline was found in DM1, with visuospatial/visuoconstructive abilities showing the greatest vulnerability to the passage of time. In addition to important clinical implications, these results suggest the need for the scientific community to delve deeper into the potential mechanisms underlying early cognitive decline in this population.

          Related collections

          Most cited references16

          • Record: found
          • Abstract: found
          • Article: not found

          Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

          Using positional cloning strategies, we have identified a CTG triplet repeat that undergoes expansion in myotonic dystrophy patients. This sequence is highly variable in the normal population. PCR analysis of the interval containing this repeat indicates that unaffected individuals have been 5 and 27 copies. Myotonic dystrophy patients who are minimally affected have at least 50 repeats, while more severely affected patients have expansion of the repeat containing segment up to several kilobase pairs. The CTG repeat is transcribed and is located in the 3' untranslated region of an mRNA that is expressed in tissues affected by myotonic dystrophy. This mRNA encodes a polypeptide that is a member of the protein kinase family.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The myotonic dystrophies: diagnosis and management.

            There are currently two clinically and molecularly defined forms of myotonic dystrophy: (1) myotonic dystrophy type 1 (DM1), also known as 'Steinert's disease'; and (2) myotonic dystrophy type 2 (DM2), also known as proximal myotonic myopathy. DM1 and DM2 are progressive multisystem genetic disorders with several clinical and genetic features in common. DM1 is the most common form of adult onset muscular dystrophy whereas DM2 tends to have a milder phenotype with later onset of symptoms and is rarer than DM1. This review will focus on the clinical features, diagnosis and management of DM1 and DM2 and will briefly discuss the recent advances in the understanding of the molecular pathogenesis of these diseases with particular reference to new treatments using gene therapy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I.

              To assess the prevalence of severe fatigue and its relation to functional impairment in daily life in patients with relatively common types of neuromuscular disorders. 598 patients with a neuromuscular disease were studied (139 with facioscapulohumeral dystrophy, 322 with adult onset myotonic dystrophy, and 137 with hereditary motor and sensory neuropathy type I). Fatigue severity was assessed with Checklist Individual Strength (CIS-fatigue). Functional impairments in daily life were measured with the short form 36 item health questionnaire (SF-36). The three different neuromuscular patient groups were of similar age and sex. Severe experienced fatigue was reported by 61-74% of the patients. Severely fatigued patients had more problems with physical functioning, social functioning, mental health, bodily pain, and general health perception. There were some differences between the three disorders in the effects of fatigue. Severe fatigue is reported by the majority of patients with relatively common types of neuromuscular disorders. Because experienced fatigue severity is associated with the severity of various functional impairments in daily life, it is a clinically and socially relevant problem in this group of patients.
                Bookmark

                Author and article information

                Contributors
                garazi.labayru@biodonostia.org
                Journal
                J Neuropsychol
                J Neuropsychol
                10.1111/(ISSN)1748-6653
                JNP
                Journal of Neuropsychology
                John Wiley and Sons Inc. (Hoboken )
                1748-6645
                1748-6653
                13 August 2019
                March 2020
                : 14
                : 1 ( doiID: 10.1111/jnp.v14.1 )
                : 121-134
                Affiliations
                [ 1 ] Neuroscience Area Biodonostia Health Research Institute Donostia‐San Sebastian Gipuzkoa Spain
                [ 2 ] Personality, Assessment and Psychological Treatment Department Psychology Faculty University of the Basque Country (UPV/EHU) Donostia‐San Sebastian Gipuzkoa Spain
                [ 3 ] Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Institute Carlos III Madrid Spain
                [ 4 ] Department of Social Psychology and Methodology of Behavioral Sciences University of the Basque Country (UPV/EHU) Donostia‐San Sebastian Gipuzkoa Spain
                [ 5 ] Neurology Department Donostia University Hospital Donostia‐San Sebastian Gipuzkoa Spain
                [ 6 ] Neurosciences Department University of the Basque Country (UPV/EHU) Donostia‐San Sebastian Gipuzkoa Spain
                Author notes
                [*] [* ]Correspondence should be addressed to Garazi Labayru, Biodonostia Health Research Institute, Paseo Doctor Beguiristain, s/n. 20014 Donostia‐San Sebastian, Spain (email: garazi.labayru@ 123456biodonostia.org ).
                Author information
                https://orcid.org/0000-0002-7304-320X
                https://orcid.org/0000-0003-2292-2164
                https://orcid.org/0000-0002-7519-6162
                https://orcid.org/0000-0002-9509-4032
                https://orcid.org/0000-0003-2511-0911
                Article
                JNP12192
                10.1111/jnp.12192
                7078919
                31407859
                c21e80cc-094b-41cc-8f15-2589b679f649
                © 2019 The Authors. Journal of Neuropsychology published by John Wiley & Sons Ltd on behalf of British Psychological Society

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 31 January 2019
                : 24 July 2019
                Page count
                Figures: 2, Tables: 4, Pages: 14, Words: 7281
                Funding
                Funded by: Institute of Health Carlos III co‐founded by Fondo Europeo de Desarrollo Regional‐FEDER
                Award ID: PI17/01231
                Award ID: PI17/01841
                Funded by: Basque Government
                Award ID: S‐PE13UN030
                Award ID: PRE_2016_1_0187
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                March 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.8 mode:remove_FC converted:18.03.2020

                Clinical Psychology & Psychiatry
                ageing,cognitive decline,longitudinal study,myotonic dystrophy type 1,visuoconstruction

                Comments

                Comment on this article